Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 39 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 42 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 18 |
| Jul 2026 | 0 | 20 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2025 Filed Jan 10, 2025 22:20 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 1,552 | $44.50 | $69,064.00 |
DisclosureSEC source: 0001415889-25-001290 · form4-01102025_050101.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,231 F3 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 22:20 UTC |
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
|
SaleCommon Stock | 1,291 | $45.34 | $58,533.94 |
DisclosureSEC source: 0001415889-25-001295 · form4-01102025_050111.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,983 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 3,500 RSUs from a January 5, 2023 grant of 14,000 RSUs. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 22:20 UTC |
Pauwels EricCHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,599 | $45.34 | $72,498.66 |
DisclosureSEC source: 0001415889-25-001294 · form4-01102025_050109.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,941 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,500 RSUs from a January 5, 2023 grant of 18,000 RSUs. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 22:20 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 2,142 | $45.34 | $97,118.28 |
DisclosureSEC source: 0001415889-25-001293 · form4-01102025_050107.xml · nonDerivative · entry 1 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,232 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 22:20 UTC |
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
|
SaleCommon Stock | 810 | $45.34 | $36,725.40 |
DisclosureSEC source: 0001415889-25-001292 · form4-01102025_050105.xml · nonDerivative · entry 1 Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,849 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,666 RSUs from a January 5, 2023 grant of 10,640 RSUs. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 1,543 | $45.34 | $69,959.62 |
DisclosureSEC source: 0001415889-25-001291 · form4-01102025_050103.xml · nonDerivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,846 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 22:20 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 55 | $45.34 | $2,493.70 |
DisclosureSEC source: 0001415889-25-001290 · form4-01102025_050101.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 6,082 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 177 RSUs from a January 5, 2023 grant of 710 RSUs. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 22:20 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 1,265 | $45.34 | $57,355.10 |
DisclosureSEC source: 0001415889-25-001290 · form4-01102025_050101.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,783 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Young AlethiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001029 · form4-01072025_050130.xml · derivative · entry 2 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Young AlethiaDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001029 · form4-01072025_050130.xml · nonDerivative · entry 1 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,067 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
ZELDIS JEROME BDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001030 · form4-01072025_050132.xml · derivative · entry 2 ZELDIS JEROME B · CIK 0001433982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
ZELDIS JEROME BDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001030 · form4-01072025_050132.xml · nonDerivative · entry 1 ZELDIS JEROME B · CIK 0001433982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
STEELE GLENN JR MD PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001028 · form4-01072025_050128.xml · derivative · entry 2 STEELE GLENN JR MD PHD · CIK 0001269131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
STEELE GLENN JR MD PHDDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001028 · form4-01072025_050128.xml · nonDerivative · entry 1 STEELE GLENN JR MD PHD · CIK 0001269131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
SOUTHWELL DAVID PDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001027 · form4-01072025_050126.xml · derivative · entry 3 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
SOUTHWELL DAVID PDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001027 · form4-01072025_050126.xml · nonDerivative · entry 1 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,850 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Smith Mary L.Director
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001026 · form4-01072025_050124.xml · derivative · entry 2 Smith Mary L. · CIK 0001866044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Smith Mary L.Director
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001026 · form4-01072025_050124.xml · nonDerivative · entry 1 Smith Mary L. · CIK 0001866044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,813 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Reeve EmmaDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001025 · form4-01072025_050122.xml · derivative · entry 2 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2034-02-15 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Reeve EmmaDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001025 · form4-01072025_050122.xml · nonDerivative · entry 1 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,200 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Okey StephanieDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001024 · form4-01072025_050120.xml · derivative · entry 2 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Okey StephanieDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001024 · form4-01072025_050120.xml · nonDerivative · entry 1 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,867 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Jacobson Allan StevenDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001023 · form4-01072025_050118.xml · derivative · entry 2 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Jacobson Allan StevenDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001023 · form4-01072025_050118.xml · nonDerivative · entry 1 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,348 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
SCHMERTZLER MICHAELDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001022 · form4-01072025_050115.xml · derivative · entry 2 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
SCHMERTZLER MICHAELDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001022 · form4-01072025_050115.xml · nonDerivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,266 F1 · shares: Restricted stock units granted on January 3, 2025 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 17, 2025 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001021 · form4-01072025_050113.xml · derivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2025-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001021 · form4-01072025_050113.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,274 F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001020 · form4-01072025_050111.xml · derivative · entry 2 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2035-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001020 · form4-01072025_050111.xml · nonDerivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,389 F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 47,500 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001019 · form4-01072025_050109.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2035-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
GrantCommon Stock | 715 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001019 · form4-01072025_050109.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 6,137 F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
GrantCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001019 · form4-01072025_050109.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,048 F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001018 · form4-01072025_050107.xml · derivative · entry 2 Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001018 · form4-01072025_050107.xml · nonDerivative · entry 1 Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,659 F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Pauwels EricCHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001017 · form4-01072025_050105.xml · derivative · entry 2 Pauwels Eric · CIK 0001323212 · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2035-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Pauwels EricCHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001017 · form4-01072025_050105.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,540 F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 56,250 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001016 · form4-01072025_050103.xml · derivative · entry 2 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2035-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001016 · form4-01072025_050103.xml · nonDerivative · entry 1 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,771 F1 · price: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. F2 · balance_after: Includes 339 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $46.54 | $0.00 |
DisclosureSEC source: 0001415889-25-001015 · form4-01072025_050101.xml · derivative · entry 2 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2035-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:20 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001015 · form4-01072025_050101.xml · nonDerivative · entry 1 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,374 F1 · shares: Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026. F2 · balance_after: Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:21 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 8,279 | $45.16 | $373,879.64 |
DisclosureSEC source: 0001415889-25-000580 · form4-01032025_100132.xml · nonDerivative · entry 1 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,528 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,988 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 17 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,512 Underlying: Common Stock · 1,988 shares Expires 2029-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,720 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 16 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,110 Underlying: Common Stock · 7,720 shares Expires 2029-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 15 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,070 Underlying: Common Stock · 600 shares Expires 2029-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. F8 · derivative.exercise_date: Currently exercisable. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 88 | $54.14 | $4,764.32 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 12 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,389 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 1,900 | $53.13 | $100,947.00 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 11 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,477 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. F7 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
Exercise / conversionCommon Stock | 1,988 | $33.02 | $65,643.76 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 10 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 1,405 | $54.05 | $75,940.25 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 9 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,389 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.025 to $54.16 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:20 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 6,315 | $53.14 | $335,579.10 |
DisclosureSEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 8 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,794 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023. F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to 53.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.